NEWSWORTHY
Japanese team plans to use iPS cells in clinical trial for cancer patients
A Japanese team is preparing a clinical trial to inject immune cells made from induced pluripotent stem (iPS) cells into patients with head and neck cancer, it has been learned. The team of Riken and Chiba University researchers will file for state approval of the ...
Kyoto University performs world's first iPS cell transplant for Parkinson's
Researchers hope to develop the treatment into a method that can be covered under Japan’s health insurance system.
Blood transfusions with iPS cells OK'd by Japanese health ministry
The advanced treatment is expected to give people with uncontrollable diseases a better way to increase their platelet counts at a time when blood donors are drying up.
A Kyoto University research team will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson’s disease, in what will be the world’s first application of iPS technology to the progressive neurological disorder.
Kyoto University reprograms stem cells to fight Parkinson's in monkeys, a breakthrough for therapy
Japanese researchers successfully engineered cells to relieve Parkinson’s symptoms in clinical trials, taking a step closer to a potential cure.
U.S. approves breakthrough gene therapy for childhood leukemia
Opening a new era in cancer care, U.S. health officials on Wednesday approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia. The Food and Drug Administration called the approval historic — the ...
30% of Japanese may reject transplants of iPS cells derived from others: study
Some 30 percent of Japanese may experience rejection after receiving transplants of cells developed from induced pluripotent stem (iPS) cells derived from someone other than the patient, a Japanese research team has found. The team, including Hiroshi Kawamoto, professor at Kyoto University's Institute for Frontier ...
Fertile offspring produced from sterile mice using iPS cells
A team of Japanese and British scientists has succeeded in producing fertile offspring from sterile mice made with a chromosomal abnormality by using induced pluripotent stem cells, better known as iPS cells, Kyoto University said Friday. The researchers, including professor Michinori Saito of Kyoto University, ...
World's first method for mass-producing platelets from iPS cells unveiled by Kyoto startup
A Kyoto startup unveils a way to mass-produce platelets, a key component in clotting, that could reduce doctors’ dependency on donated blood to minimize bleeding.
First-ever trial of drug using iPS cells to begin at Kyoto University
Kyoto University researchers are set to begin the world's first clinical trial of a drug identified using iPS cells to treat a rare bone disease, the university said Tuesday. A team led by Junya Toguchida, a professor at the university, used induced pluripotent stem cells ...
Transplants using iPS cells put Riken specialist at forefront of regenerative medicine research
When she entered medicine in the mid-1980s, Masayo Takahashi chose ophthalmology as her specialty, she said, because she wanted to have a family and thought the discipline would spare her from sudden work calls in the middle of the night, helping her best balance ...
Todai-led team creates mouse pancreas in rat in treatment breakthrough
A team led by University of Tokyo researchers has successfully created a healthy pancreas from mouse stem cells inside the body of a rat, in a first between different species, a study published in the British science journal Nature showed. The pancreas, later transplanted into ...
